Ahrén B, Schweizer A, Dejager S, Dunning BE, Nilsson PM, Persson M, Foley JE. 1- J Clin Endocrinol Metab. 2009;94(4): 1236-43 Vildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetes, J Clin Endocrinol Metab 94(94):1236-43, 2009
Ahrén B, Foley JE. The islet enhancer vildagliptin: mechanisms of improved glucose metabolism, Int J Clin Pract Suppl. 159:8-14, 2008
Mari A, Scherbaum WA, Nilsson PM, Lalanne G, Schweizer A, Dunning BE, Jauffret S, Foley JE. Characterization of the influence of vildagliptin on model-assessed -cell function in patients with type 2 diabetes and mild hyperglycemia, J Clin Endocrinol Metab 93(93):103-9, 2008
He YL, Wang Y, Bullock JM, Deacon CF, Holst JJ, Dunning BE, Ligueros-Saylan M, Foley JE. Pharmacodynamics of vildagliptin in patients with type 2 diabetes during OGTT, J Clin Pharmacol 47(47):633-41, 2007
Dr. James E Foley
Dirección profesional:
East Hanover , Nueva Jersey , EE.UU. , E-mail: james.foley@novartis.com
|